2-(4-Chlorothiazol-2-yl)acetic acid

Catalog No. :
ACHWBT413
CAS No. :
1392804-23-7
Molecular Formula :
C5H4ClNO2S
Molecular Weight :
177.61

IUPAC Name:2-(4-chlorothiazol-2-yl)acetic acid

2-(4-Chlorothiazol-2-yl)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$194.00Login to see priceIn stockInquiry
250mg95%$313.00Login to see priceIn stockInquiry
500mg95%$594.00Login to see priceIn stockInquiry
1g95%$906.00Login to see priceIn stockInquiry
5g95%$2796.00Login to see priceIn stockInquiry
10g95%$4999.00Login to see priceIn stockInquiry
25g95%$9998.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Chlorothiazol-2-yl)acetic acid
IUPAC Name2-(4-chlorothiazol-2-yl)acetic acid
MDL No.MFCD23106222
Molecular FormulaC5H4ClNO2S
Molecular Weight177.61
SMILESO=C(O)CC1=NC(Cl)=CS1
InChI KeyQYWLJHJXNDAOSH-UHFFFAOYSA-N
Synonym(4-Chloro-thiazol-2-yl)acetic acid | (4-Chlorothiazol-2-yl)acetic acid | 1392804-23-7 | DTXSID801302554 | MFCD23106222 | (4-Chloro-thiazol-2-yl)acetic acid, AldrichCPR | 2-(4-chlorothiazol-2-yl)aceticacid | AKOS030524930 | SY344646 | 4-Chlorothiazole-2-ac
CAS No.1392804-23-7
PubChem CID72208193

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACHWBT413 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHWBT413 route product structure diagram
    ACHWBT4131392804-23-7 In Stock
Inquiry

2. ACHWBT413 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHWBT413 route product structure diagram
    ACHWBT4131392804-23-7 In Stock
Inquiry

Comments (0)